Checkpoint Therapeutics, Inc. Quarterly Return On Assets in % from Q2 2017 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Checkpoint Therapeutics, Inc. quarterly/annual Return On Assets history and growth rate from Q2 2017 to Q3 2024.
  • Checkpoint Therapeutics, Inc. Return On Assets for the quarter ending September 30, 2024 was -659 %, a 8.81% increase year-over-year.
  • Checkpoint Therapeutics, Inc. annual Return On Assets for 2023 was -950 %, a 317% decline from 2022.
  • Checkpoint Therapeutics, Inc. annual Return On Assets for 2022 was -228 %, a 146% decline from 2021.
  • Checkpoint Therapeutics, Inc. annual Return On Assets for 2021 was -92.8 %, a 31.8% decline from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -659 +63.7 +8.81% Jul 1, 2024 Sep 30, 2024
Q2 2024 -673 -196 -41% Apr 1, 2024 Jun 30, 2024
Q1 2024 -750 -441 -143% Jan 1, 2024 Mar 31, 2024
Q4 2023 -950 -722 -317% Oct 1, 2023 Dec 31, 2023
Q3 2023 -723 -535 -286% Jul 1, 2023 Sep 30, 2023
Q2 2023 -477 -327 -218% Apr 1, 2023 Jun 30, 2023
Q1 2023 -309 -190 -160% Jan 1, 2023 Mar 31, 2023
Q4 2022 -228 -135 -146% Oct 1, 2022 Dec 31, 2022
Q3 2022 -187 -123 -191% Jul 1, 2022 Sep 30, 2022
Q2 2022 -150 -92.4 -160% Apr 1, 2022 Jun 30, 2022
Q1 2022 -119 -56.6 -91.1% Jan 1, 2022 Mar 31, 2022
Q4 2021 -92.8 -22.4 -31.8% Oct 1, 2021 Dec 31, 2021
Q3 2021 -64.3 +10.8 +14.4% Jul 1, 2021 Sep 30, 2021
Q2 2021 -57.9 +43.1 +42.7% Apr 1, 2021 Jun 30, 2021
Q1 2021 -62.1 +49.1 +44.2% Jan 1, 2021 Mar 31, 2021
Q4 2020 -70.4 +67.7 +49% Oct 1, 2020 Dec 31, 2020
Q3 2020 -75.1 +83.3 +52.6% Jul 1, 2020 Sep 30, 2020
Q2 2020 -101 +45.8 +31.2% Apr 1, 2020 Jun 30, 2020
Q1 2020 -111 +22.8 +17% Jan 1, 2020 Mar 31, 2020
Q4 2019 -138 -18 -15% Oct 1, 2019 Dec 31, 2019
Q3 2019 -158 -54 -51.8% Jul 1, 2019 Sep 30, 2019
Q2 2019 -147 -49.9 -51.5% Apr 1, 2019 Jun 30, 2019
Q1 2019 -134 -37.8 -39.2% Jan 1, 2019 Mar 31, 2019
Q4 2018 -120 -37.1 -44.7% Oct 1, 2018 Dec 31, 2018
Q3 2018 -104 -23.3 -28.7% Jul 1, 2018 Sep 30, 2018
Q2 2018 -96.9 -26.6 -37.8% Apr 1, 2018 Jun 30, 2018
Q1 2018 -96.3 Jan 1, 2018 Mar 31, 2018
Q4 2017 -83.1 Oct 1, 2017 Dec 31, 2017
Q3 2017 -81.1 Jul 1, 2017 Sep 30, 2017
Q2 2017 -70.3 Apr 1, 2017 Jun 30, 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.